Skip to main content

Day: September 20, 2022

NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes

NorthStar is further expanding commercial-scale domestic radioisotope production capabilities using IBA’s environmentally preferable Rhodotron® accelerator technology Louvain-La-Neuve, Belgium, and BELOIT, Wisconsin, USA September 20, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for medical imaging and therapeutic applications, today announced a new agreement under which NorthStar will purchase two additional Rhodotron® TT300 HE electron beam accelerators, and the associated beamlines, from IBA for the production of molybdenum-99 (Mo-99). The purchase marks a total of five Rhodotron® accelerators that NorthStar has purchased from IBA to...

Continue reading

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction

GOSSELIES, Belgium and MONT-SAINT-GUIBERT, Belgium, Sept. 20, 2022 (GLOBE NEWSWIRE) — Cellistic, the cell therapy development and manufacturing business of Ncardia BV, and Celyad Oncology (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, announced today a transaction whereby Cellistic will acquire Celyad Oncology’s Good Manufacturing Practice (GMP) grade cell therapy manufacturing capability, including the existing facility and all related personnel (the “Manufacturing Business Unit”). Under the terms of an asset purchase agreement between Celyad Oncology and Cellistic, Cellistic agreed to acquire Celyad Oncology’s Manufacturing Business Unit in Mont-Saint-Guibert, Belgium, for a total consideration of...

Continue reading

ABC arbitrage: 2022 Interim Result: : €16.2m / 2022 annualized ROE: 20.2 %

2022 Interim Result: : €16.2m 2022 annualized ROE: 20.2 % The Board of Directors of ABC arbitrage, presided by the Chairman Dominique Ceolin, met on September 15, 2022 to approve the consolidated financial statements for the first half 20221.In EUR millions June 30, 2022 IFRS June 30, 2021 IFRS Dec. 31, 2021 IFRSNet revenues €31.5m €35.1m €64.1mNet income €16.2m €16.8m €28.0mEarnings per share (EPS) €0.27 €0.29 €0.48Return On Equity (ROE) 20.2% 21.7%  17.5%  Business performance In accordance with IFRS standards, consolidated net revenue at 30 June 2022 was €31.5 million and consolidated net income amounted to €16.2 million, almost flat (-3.6%) compared to the first half of 2021. The first half of 2022 was impacted by the war in Ukraine, a situation unknown in Europe since the...

Continue reading

Basilea announces acquisition of rights for oncology asset BAL0891 by SillaJen and updates financial guidance

Upfront and near-term milestone payments of USD 14 million Additional milestone payments of approximately USD 320 million and tiered royalties on net sales Second oncology transaction as part of strategic refocusing on anti-infectives Full-year 2022 revenue guidance increased, resulting in improved expected operating result and operating cash flowAd hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, September 20, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an asset purchase agreement and a sub-license agreement with SillaJen, Inc. for Basilea’s novel kinase inhibitor, BAL0891, a potential first-in-class mitotic checkpoint inhibitor, that drives...

Continue reading

Capital Markets Day: Building Telenor for the future

(Fornebu, 20 September 2022) Today, at its Capital Markets Day, Telenor presents significant changes to ensure growth and reshape the company’s role as an enabler for digitalisation and sustainability. The company will become a leading telecom operator and infrastructure player in the Nordics and take leading positions in security and IoT services. In Asia, Telenor will, together with partners, build scale and take number one positions in several markets. “The Telenor you see today is not the Telenor you will see in the future. We are taking a big step forward to ensure more value for our customers in an increasingly digital world in need of secure, stable, and sustainable solutions. We are building a smarter and more flexible Telenor – a company that creates value for customers, society, and shareholders,” says Sigve Brekke, CEO of Telenor...

Continue reading

Customers consider insurers as preferred providers for physical and financial wellness advice

Capgemini Press ContactsKeelan Kunda (North America)Tel.:+ 1 (212) 551-4875E-mail: kkunda@we-worldwide.com Josh Graham (EMEA) Tel.: +44 7518 799 630 E-mail: jgraham@we-worldwide.com Qorus Press ContactJana LednarovaTel.: +421 915 225611E-mail: jana@qorusglobal.com  Customers consider insurers as preferred providers for physical and financial wellness advice Over two thirds of customers are interested in physical and financial wellness,yet only 8% of insurers have established the necessary capabilities. Paris, September 20, 2022 – Capgemini and Qorus’ inaugural World Life and Health Insurance Report, published today, reveals that customers consider insurers among the top two preferred providers1 for physical and financial wellness advice. However, most insurers do not focus on engaging customers and educating them on how to adopt and consistently...

Continue reading

Alkaline Fuel Cell Power Corp. Executes Letter of Intent with Progressus Clean Technologies Inc. for Industry-Leading Clean Hydrogen Joint Venture Pilot

Figure 1 Channce Fuller, President and CEO of Progressus and Frank Carnevale, CEO of Alkaline Fuel Cell Power Corp. shake hands upon finalizing the LOI.Figure 2 AFCP’s conceptual designs for the 4 kW Micro-CHP and 10 kW Fuel Cell Generator systemsPilot project to provide in-field proof of concept and operational data Advancing a potential solution for global utility companies to blend hydrogen and natural gas JV structured to support potential future growth and additional partnershipsTORONTO, Sept. 20, 2022 (GLOBE NEWSWIRE) — Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (“AFCP” or the “Company”), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce the execution of a letter of intent (“LOI”) with Progressus...

Continue reading

Christina Lake Affirms Mark Aiken’s Appointment as CEO

VANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that further to the news release dated August 4, 2022, Health Canada has cleared Mark Aiken’s mandatory Security Clearance and he has been officially been appointed as Chief Executive Officer (“CEO”) of the Company, effective September 16, 2022. Following Mr. Aiken’s appointment as CEO of Christina Lake Cannabis, current interim-CEO Joel Dumaresq has stepped down from this position. Mr. Dumaresq will remain a member of CLC’s Board of Directors. CLC would like to thank Mr. Dumaresq for his dedication, commitment, and leadership in helping to build the foundation for the Company. About Christina Lake Cannabis Corp. Christina...

Continue reading

Aemetis Signs Agreement With Cathay Pacific to Supply 38 Million Gallons of Sustainable Aviation Fuel

Fuel to be Delivered to San Francisco International Airport CUPERTINO, CA, Sept. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable fuels company focused on negative carbon intensity products, announced today the volume of an offtake agreement that has been signed with Cathay Pacific Airways Limited (“Cathay Pacific”) for 38 million gallons of blended sustainable aviation fuel (“SAF”) to be delivered over the 7 year term of the agreement. Sustainable aviation fuel provides significant environmental benefits compared to petroleum jet fuel, including a lower lifecycle carbon footprint and reduced contrails. The blended sustainable aviation fuel to be supplied under this agreement is 40% SAF and 60% Petroleum Jet A to meet international blending standards. The supply agreement with Aemetis builds...

Continue reading

Jura Announces Increase to Running Finance Facility and Operations Update

CALGARY, Alberta, Sept. 19, 2022 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura”) announces that its wholly-owned subsidiary, Spud Energy Pty Limited (“SEPL”), has entered into a supplemental short term running finance facility agreement (the “Facility”), pursuant to which the amount of the Facility has been increased from Pakistan Rupees (“PKR”) 425 million (approximately US$1.80 million using the State Bank of Pakistan September 19, 2022 exchange rate of US$1 = PKR235.88) to PKR 625 million (approximately US$2.65 million). The Facility has been extended by JS Bank Limited, a related party of Jura, and carries interest at the rate of 1-month Karachi Inter Bank Offered Rate (16.07% using the State Bank of Pakistan posted rate on September 19, 2022) plus 2%, maturing twelve months from the date of disbursement. The interest is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.